Design Therapeutics, Inc. (DSGN) Form 10-K Annual Reports
Design Therapeutics, Inc. (DSGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DSGN
CIK: 1807120
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRyan Rowland
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005487 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005202 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001193125-26-329579 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-329570 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267732 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001478916-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001579826-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001754129-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001559570-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001751873-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-09 | 8-K | 0001193125-26-267485 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-09 | — | SCHEDULE 13G Filing | 0000919574-26-003921 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001193125-26-227875 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003492 | View SEC Doc Filr Page |
| 10-Q | 2026-04-28 | 2026-03-31 | 10-Q | 0001193125-26-187063 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-28 | 8-K | 0001193125-26-187012 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001193125-26-173689 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2026-04-23 | DEF 14A | 0001193125-26-173678 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001193125-26-173640 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-31 | 4 Filing | 0001559570-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-03-31 | 3 Filing | 0001559570-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-04-01 | 2026-03-31 | 8-K | 0001193125-26-137861 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-11 | — | SCHEDULE 13D/A Filing | 0001072613-26-000257 | View SEC Doc Filr Page |
| S-8 | 2026-03-09 | — | S-8 | 0001193125-26-098540 | View SEC Doc Filr Page |
| 10-K | 2026-03-09 | 2025-12-31 | 10-K | 0001193125-26-098491 | View SEC Doc Filr Page |